150 related articles for article (PubMed ID: 6220993)
1. [Plasmapheresis therapy. Immunopathologic concepts].
Rother K; Thies K
Internist (Berl); 1983 Jan; 24(1):1-13. PubMed ID: 6220993
[No Abstract] [Full Text] [Related]
2. Indications and limitations of therapeutic plasmapheresis.
Kater L
Neth J Med; 1981; 24(6):206-8. PubMed ID: 6459532
[No Abstract] [Full Text] [Related]
3. [Recent developments in high-dose immunoglobulin therapy: therapeutic plasma exchange, autoimmune diseases].
Kalden JR; Schranz W; Lösch G; Krapf F; Bartels O
Beitr Infusionther Klin Ernahr; 1982; 9():48-59. PubMed ID: 6216881
[No Abstract] [Full Text] [Related]
4. Methods available for plasma component removal.
Smith JW
Trans Am Soc Artif Intern Organs; 1984; 30():694-5. PubMed ID: 6241972
[No Abstract] [Full Text] [Related]
5. Transfusion medicine 1994.
Pineda A; Korbling M; Rock GA
Rev Invest Clin; 1994 Apr; Suppl():101-15. PubMed ID: 7886293
[No Abstract] [Full Text] [Related]
6. [Therapeutic plasma exchange: indications and results].
Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G
Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729
[No Abstract] [Full Text] [Related]
7. The treatment of immune glomerular disease.
Williams DG
Springer Semin Immunopathol; 1987; 9(4):417-29. PubMed ID: 2963398
[No Abstract] [Full Text] [Related]
8. Antibody rebound after plasmapheresis: experimental evidence and clinical consequences.
Schroeder JO; Euler HH
Prog Clin Biol Res; 1990; 337():415-7. PubMed ID: 2141173
[No Abstract] [Full Text] [Related]
9. [Plasmapheresis in the treatment of diseases caused by immunologic pathology].
Gorodetskiĭ VM; Ryzhko VV
Ter Arkh; 1984; 56(6):19-23. PubMed ID: 6236574
[TBL] [Abstract][Full Text] [Related]
10. Management of immune-mediated and paraproteinemic diseases by membrane plasma separation and cascade filtration.
Valbonesi M; Garelli S; Montani F; Cefis M; Rossi U
Vox Sang; 1982; 43(2):91-101. PubMed ID: 6214891
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with limited plasma exchange as a mode of therapy in some immunological diseases.
Malaviya AN; Nanu A; Taneja N; Raina V; Pati A; Garg R; Rana DS; Narayanan K
J Assoc Physicians India; 1982 Dec; 30(12):899-901. PubMed ID: 6223917
[No Abstract] [Full Text] [Related]
12. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
[TBL] [Abstract][Full Text] [Related]
13. [Nephrology update--IV. Rapidly progressing glomerulonephritis].
Fünfstück R; Stein G
Med Klin (Munich); 1996 Oct; 91(10):632-9. PubMed ID: 9019640
[No Abstract] [Full Text] [Related]
14. [Therapeutic plasmapheresis (review of the literature)].
Terekhov NT; Lomatchenko VF
Vrach Delo; 1984 Dec; (12):4-9. PubMed ID: 6240829
[No Abstract] [Full Text] [Related]
15. Plasmapheresis combined with lymphocytapheresis and cytotoxic drugs as a therapeutic modality in neuroimmunological diseases.
Valbonesi M; Montani F; Florio G; Zerbi D; Beltramelli A
Ital J Neurol Sci; 1984 Mar; 5(1):35-40. PubMed ID: 6329999
[TBL] [Abstract][Full Text] [Related]
16. The role of therapeutic plasmapheresis in the rheumatic diseases.
Jones JV; Clough JD; Klinenberg JR; Davis P
J Lab Clin Med; 1981 May; 97(5):589-98. PubMed ID: 6452484
[No Abstract] [Full Text] [Related]
17. [Methods of extracorporeal therapy of rheumatic diseases].
Shilkina NP; Pukhov AG
Revmatologiia (Mosk); 1986; (2):57-63. PubMed ID: 2944207
[No Abstract] [Full Text] [Related]
18. Synergy between plasma exchange and intravenous immunoglobulin.
Nydegger UE; Rieben R; Jungi TW
Curr Stud Hematol Blood Transfus; 1990; (57):31-50. PubMed ID: 2148718
[No Abstract] [Full Text] [Related]
19. Plasmapheresis in intensive care. Part 2 of 2: indications for plasmapheresis and plasma exchange in the intensive care unit.
Hart GK
Intensive Care World; 1990 Jun; 7(2):80-4. PubMed ID: 10148103
[No Abstract] [Full Text] [Related]
20. What are the established clinical indications for therapeutic plasma exchange and how important is the choice of replacement fluid for efficacy of therapeutic plasma exchange in these situations?
Vox Sang; 1982 Nov; 43(5):270-95. PubMed ID: 6216664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
